No. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered commercial, not medical. Because 23andMe is not a medical company, customers' ...
Home genetics company 23andMe continues to struggle as demand for casual gene tracing declines. On Monday, the company announced that it has decided on a restructuring ...
By eliminating hundreds of jobs and stripping the therapeutic programs, 23andMe expects to save around $35 million. The company, once valued at $6 billion, experienced a severe drop in share prices ...